Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · IEX Real-Time Price · USD
57.69
+0.15 (0.26%)
At close: Jul 26, 2024, 4:00 PM
56.53
-1.16 (-2.01%)
After-hours: Jul 26, 2024, 6:29 PM EDT

PRAX Revenue

Praxis Precision Medicines had revenue of $431.00K in the quarter ending March 31, 2024, a decrease of -36.90%. This brings the company's revenue in the last twelve months to $2.20M, up 221.38% year-over-year. In the year 2023, Praxis Precision Medicines had annual revenue of $2.45M.

Revenue (ttm)
$2.20M
Revenue Growth
+221.38%
P/S Ratio
449.64
Revenue / Employee
$26,768
Employees
82
Market Cap
986.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.45M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Embecta 1.13B
OPKO Health 799.60M
Pacira BioSciences 681.75M
CareDx 275.11M
Bicycle Therapeutics 41.61M
Silence Therapeutics 33.86M
ARS Pharmaceuticals 10.00K
Revenue Rankings